Market Cap (In CNY)
5.45 Billion
Revenue (In CNY)
4.26 Billion
Net Income (In CNY)
-414.51 Million
Avg. Volume
25.23 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2.98-8.35
- PE
- -
- EPS
- -
- Beta Value
- 0.458
- ISIN
- CNE100000PY3
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Min Niu
- Employee Count
- -
- Website
- https://www.gzbl.com
- Ipo Date
- 2010-06-03
- Details
- Guizhou Bailing Group Pharmaceutical Co., Ltd. researches, develops, produces, and sells Chinese medicines in China. The company provides medicines in the form of tablets, capsules, granules, syrups, pills, powders, tinctures, sprays, and ointments for cardiovascular and cerebrovascular diseases, cough, cold, pediatric, and gynecologic diseases. Guizhou Bailing Group Pharmaceutical Co., Ltd. was founded in 2005 and is based in Anshun, China.
More Stocks
-
RAJRATANRajratan Global Wire Limited
RAJRATAN
-
SABSW
-
SANCOSanco Industries Limited
SANCO
-
9519RENOVA, Inc.
9519
-
SAGARSOFTSagarsoft (India) Limited
SAGARSOFT
-
REYN
-
TGLOtheglobe.com, inc.
TGLO
-
HCH